121 related articles for article (PubMed ID: 23676787)
1. Hepatitis B DNA vaccine-polycation nano-complexes enhancing immune response by percutaneous administration with microneedle.
Yin D; Liang W; Xing S; Gao Z; Zhang W; Guo Z; Gao S
Biol Pharm Bull; 2013; 36(8):1283-91. PubMed ID: 23676787
[TBL] [Abstract][Full Text] [Related]
2. Effective humoral immune response from a H1N1 DNA vaccine delivered to the skin by microneedles coated with PLGA-based cationic nanoparticles.
Seok H; Noh JY; Lee DY; Kim SJ; Song CS; Kim YC
J Control Release; 2017 Nov; 265():66-74. PubMed ID: 28434892
[TBL] [Abstract][Full Text] [Related]
3. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine.
Fakharzadeh S; Kalanaky S; Hafizi M; Goya MM; Masoumi Z; Namaki S; Shakeri N; Abbasi M; Mahdavi M; Nazaran MH
Vaccine; 2013 May; 31(22):2591-7. PubMed ID: 23583463
[TBL] [Abstract][Full Text] [Related]
4. Low-Molecular Weight Polyethylenimine Modified with Pluronic 123 and RGD- or Chimeric RGD-NLS Peptide: Characteristics and Transfection Efficacy of Their Complexes with Plasmid DNA.
Hu J; Zhao W; Liu K; Yu Q; Mao Y; Lu Z; Zhang Y; Zhu M
Molecules; 2016 May; 21(5):. PubMed ID: 27213305
[TBL] [Abstract][Full Text] [Related]
5. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
[TBL] [Abstract][Full Text] [Related]
6. DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN.
Qiu Y; Guo L; Zhang S; Xu B; Gao Y; Hu Y; Hou J; Bai B; Shen H; Mao P
Drug Deliv; 2016 Sep; 23(7):2391-2398. PubMed ID: 25625495
[TBL] [Abstract][Full Text] [Related]
7. Cationic transfersomes based topical genetic vaccine against hepatitis B.
Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
[TBL] [Abstract][Full Text] [Related]
8. Superparamagnetic nanoparticles for effective delivery of malaria DNA vaccine.
Al-Deen FN; Ho J; Selomulya C; Ma C; Coppel R
Langmuir; 2011 Apr; 27(7):3703-12. PubMed ID: 21361304
[TBL] [Abstract][Full Text] [Related]
9. On the efficacy of malaria DNA vaccination with magnetic gene vectors.
Nawwab Al-Deen F; Ma C; Xiang SD; Selomulya C; Plebanski M; Coppel RL
J Control Release; 2013 May; 168(1):10-7. PubMed ID: 23500060
[TBL] [Abstract][Full Text] [Related]
10. Design of magnetic polyplexes taken up efficiently by dendritic cell for enhanced DNA vaccine delivery.
Nawwab Al-Deen FM; Selomulya C; Kong YY; Xiang SD; Ma C; Coppel RL; Plebanski M
Gene Ther; 2014 Feb; 21(2):212-8. PubMed ID: 24352195
[TBL] [Abstract][Full Text] [Related]
11. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.
Hu K; Dou J; Yu F; He X; Yuan X; Wang Y; Liu C; Gu N
Vaccine; 2011 Feb; 29(7):1455-62. PubMed ID: 21185849
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle formulation enhanced protective immunity provoked by PYGPI8p-transamidase related protein (PyTAM) DNA vaccine in Plasmodium yoelii malaria model.
Cherif MS; Shuaibu MN; Kodama Y; Kurosaki T; Helegbe GK; Kikuchi M; Ichinose A; Yanagi T; Sasaki H; Yui K; Tien NH; Karbwang J; Hirayama K
Vaccine; 2014 Apr; 32(17):1998-2006. PubMed ID: 24440206
[TBL] [Abstract][Full Text] [Related]
13. Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles.
Coulman SA; Barrow D; Anstey A; Gateley C; Morrissey A; Wilke N; Allender C; Brain K; Birchall JC
Curr Drug Deliv; 2006 Jan; 3(1):65-75. PubMed ID: 16472095
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccination for cervical cancer: Strategic optimisation of RALA mediated gene delivery from a biodegradable microneedle system.
Cole G; Ali AA; McCrudden CM; McBride JW; McCaffrey J; Robson T; Kett VL; Dunne NJ; Donnelly RF; McCarthy HO
Eur J Pharm Biopharm; 2018 Jun; 127():288-297. PubMed ID: 29510205
[TBL] [Abstract][Full Text] [Related]
15. Immunological evaluation of colonic delivered Hepatitis B surface antigen loaded TLR-4 agonist modified solid fat nanoparticles.
Sahu KK; Pandey RS
Int Immunopharmacol; 2016 Oct; 39():343-352. PubMed ID: 27526270
[TBL] [Abstract][Full Text] [Related]
16. Intranasal delivery of plasmids expressing bovine herpesvirus 1 gB/gC/gD proteins by polyethyleneimine magnetic beads activates long-term immune responses in mice.
Liu XB; Yu GW; Gao XY; Huang JL; Qin LT; Ni HB; Lyu C
Virol J; 2021 Mar; 18(1):60. PubMed ID: 33743745
[TBL] [Abstract][Full Text] [Related]
17. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
[TBL] [Abstract][Full Text] [Related]
18. [The effect of HPV16E7 DNA vaccine transdermal delivery with microneedle array].
Gao H; Pan JC; Chen B; Xue ZF; Li HD
Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Sep; 42(9):663-6. PubMed ID: 19175177
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy and hepatitis B virus clearance in mice enhanced by cell-mediated immunity with novel prime-boost regimens.
Chuai X; Chen P; Chen H; Wang W; Deng Y; Ruan L; Li W; Tan W
J Viral Hepat; 2017 Apr; 24(4):337-345. PubMed ID: 27885748
[TBL] [Abstract][Full Text] [Related]
20. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.
Jain S; Singh P; Mishra V; Vyas SP
Immunol Lett; 2005 Oct; 101(1):41-9. PubMed ID: 15869802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
